Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy
- 1 June 2002
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 29 (12) , 949-956
- https://doi.org/10.1038/sj.bmt.1703574
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 28 references indexed in Scilit:
- Mixed Chimerism as an Approach to Transplantation ToleranceClinical Immunology, 2000
- Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response.Journal of Clinical Investigation, 1997
- Rapamycin Prolongs Survival of Murine Recipients of Fully Allogeneic Donor Grafts When Administered during the Graft‐versus‐Host Disease ProcessaAnnals of the New York Academy of Sciences, 1993
- Mls — a retrovirus exploits the immune systemImmunology Today, 1991
- Genes encoding ligands for deletion of Vβ11 T cells cosegregate with mammary tumour virus genomesNature, 1991
- Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.Proceedings of the National Academy of Sciences, 1990
- Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens.The Journal of Experimental Medicine, 1990
- DRUG-INDUCED TOLERANCE TO ALLOGRAFTS IN MICETransplantation, 1986
- Monoclonal antibodies to promote marrow engraftment and tissue graft toleranceNature, 1986
- Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenograftsNature, 1984